Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611, Luxembourg, Luxembourg
CIAMBRA 100 mg powder for concentrate for solution for infusion.
Pharmaceutical Form |
---|
Powder for concentrate for solution for infusion. White to almost white lyophilised powder. The pH of the reconstituted solution is between 6.6 and 7.8. The Osmolality of the reconstituted solution is 230-270 mOsmol/kg. |
One vial of powder contains 100 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
After reconstitution (see section 6.6), each vial contains 25 mg/ml of pemetrexed.
Excipient with known effect: Each vial contains approximately 11 mg sodium.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Pemetrexed |
Pemetrexed is a folate analog metabolic inhibitor that exerts its action by disrupting folate-dependent metabolic processes essential for cell replication. In vitro studies have shown that pemetrexed inhibits thymidylate synthase (TS), dihydrofolate reductase (DHFR), glycinamide ribonucleotide formyltransferase (GARFT) and and to a lesser extent aminoimidazole carboxamide ribonucleotide formyltransferase (AICARFT), which are folate-dependent enzymes involved in the de novo biosynthesis of thymidine and purine nucleotides. Pemetrexed is taken into cells by membrane carriers such as the reduced folate carrier and membrane folate binding protein transport systems. Once in the cell, pemetrexed is converted to polyglutamate forms by the enzyme folylpolyglutamate synthetase. The polyglutamate forms are retained in cells and are inhibitors of TS and GARFT. Polyglutamation is a time- and concentration-dependent process that occurs in tumor cells and, is thought to occur to a lesser extent, in normal tissues. Polyglutamated metabolites are thought to have an increased intracellular half-life resulting in prolonged drug action in malignant cells. |
List of Excipients |
---|
Mannitol (E421) |
Type I glass vial with chlorobutyl rubber stopper and an aluminium seal with flip off cap. The vial is covered with a shrink-wrapped plastic sleeve. Each 10 ml vial contains 100 mg of pemetrexed (as pemetrexed disodium hemipentahydrate).
Pack of 1 vial.
Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, L-1611, Luxembourg, Luxembourg
EU/1/15/1055/001
Date of first authorisation: 2 December 2015
Date of latest renewal: 23 July 2020
Drug | Countries | |
---|---|---|
CIAMBRA | Austria, Estonia, Croatia, Ireland, Lithuania, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.